此页面是自动翻译的，不保证翻译的准确性。请参阅英文版对于源文本。

搜索临床试验以：Targetable mutations

总计1110个结果

Institut für Klinische Krebsforschung IKF GmbH...
Roche Pharma AG

完全的

PLATON - 分析靶向肿瘤突变的平台（试点研究） (PLATON)

胃癌 | 胰腺癌 | 胆管癌 | 胆囊癌 | 肝细胞癌 | 食道癌

德国
Trans Tasman Radiation Oncology Group
Thoracic Oncology Group Australasia (TOGA)

尚未招聘

Moderately Hypofractionated Versus Conventional Chemoradiotherapy With Consolidation Immunotherapy in Patients With Unresectable, Non-Targetable Stage III Non Small Cell Lung Cancer (NSCLC) (MODERN-LUNG)

第三期非小细胞肺癌
Hutchmed

尚未招聘

HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 Mutations

具有IDH1或IDH2突变的2级星形细胞瘤或少突胶质细胞瘤
Yale University
Foundation Medicine

尚未招聘

Prospective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for Detection of Estrogen Receptor 1 (ESR1) Mutations in (Human Epidermal Growth Factor Receptor) HR+/HER2- Metastatic Breast Cancer (MBC)

乳腺癌 | 转移性乳腺癌 | HR+/HER- Metastatic Breast Cancer

美国
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

尚未招聘

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

实体瘤 | RAS突变

中国

这是预览

登录或创建免费账户，即可查看所有匹配的试验并使用完整搜索功能。

订阅